ORIENT BIO Inc. (KRX:002630)

ORIENT BIO Ratios and Metrics

Market cap in millions KRW. Fiscal year is April - March.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb 4, 2026	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Market Capitalization	63,553	187,317	58,433	107,869	176,914	194,884
Market Cap Growth	-71.31%	220.57%	-45.83%	-39.03%	-9.22%	-14.92%
Enterprise Value	-	190,173	60,013	198,892	236,940	251,125
Last Close Price	536.00	1580.00	574.00	1059.72	2347.29	2617.72
PS Ratio	1.08	3.60	1.57	3.55	6.90	1.79
PB Ratio	1.20	3.86	1.11	1.72	2.21	2.14
P/TBV Ratio	1.21	3.88	1.12	1.67	4.02	3.71
P/FCF Ratio	6.81	22.08	-	-	-	-
P/OCF Ratio	5.41	21.43	-	-	-	-
EV/Sales Ratio	-	3.66	1.61	6.55	9.25	2.30
EV/EBITDA Ratio	-	649.60	-	-	-	-
EV/FCF Ratio	-	22.42	-	-	-	-
Debt / Equity Ratio	0.20	0.17	0.18	0.13	0.80	0.57
Debt / EBITDA Ratio	7.96	27.69	-	-	-	-
Debt / FCF Ratio	1.14	0.96	-	-	-	-
Asset Turnover	0.72	0.71	0.47	0.22	0.14	0.64
Inventory Turnover	5.30	4.74	3.42	1.35	0.78	3.30
Quick Ratio	1.11	1.32	0.98	1.14	0.63	0.70
Current Ratio	1.80	1.91	1.75	2.17	1.06	1.37
Return on Equity (ROE)	-12.42%	-30.93%	-22.15%	-18.49%	-15.34%	-27.72%
Return on Assets (ROA)	-2.20%	-3.73%	-11.84%	-4.46%	-2.78%	-3.58%
Return on Invested Capital (ROIC)	-5.44%	-8.47%	-25.28%	-11.54%	-6.83%	-7.42%
Return on Capital Employed (ROCE)	-4.80%	-7.80%	-24.30%	-14.20%	-7.90%	-9.00%
Earnings Yield	-10.78%	-8.35%	-20.53%	-18.08%	-7.84%	-10.05%
FCF Yield	14.68%	4.53%	-7.95%	-25.61%	-2.80%	-5.33%
Buyback Yield / Dilution	-8.36%	-9.70%	-32.48%	-8.49%	-2.09%	-10.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.